Cicognola, Claudia http://orcid.org/0000-0003-1806-7089
Brinkmalm, Gunnar
Wahlgren, Jessica
Portelius, Erik
Gobom, Johan
Cullen, Nicholas C.
Hansson, Oskar
Parnetti, Lucilla
Constantinescu, Radu
Wildsmith, Kristin
Chen, Hsu-Hsin
Beach, Thomas G.
Lashley, Tammaryn
Zetterberg, Henrik
Blennow, Kaj
Höglund, Kina
Funding for this research was provided by:
Vetenskapsrådet (-)
European Research Council (-)
Torsten Söderbergs Stiftelse (-)
Knut och Alice Wallenbergs Stiftelse (-)
Konung Gustaf V:s och Drottning Victorias Frimurarestiftelse (-)
Stiftelsen för Gamla Tjänarinnor (-)
Ågrens Stiftelse (-)
Swedish Alzheimer's Foundation (-)
Swedish Brain Foundation (-)
National Institute of Neurological Disorders and Stroke (U24 NS072026)
National Institute on Aging (P30 AG19610)
Arizona Department of Health Services (211002)
Arizona Biomedical Research Commission (4001, 0011, 05-901, 1001)
Michael J. Fox Foundation for Parkinson's Research (-)
Reta Lila Weston Institute for Neurological Studies (-)
Progressive Supranuclear Palsy Association (-)
Alzheimer's Research UK (-)
Article History
Received: 22 October 2018
Revised: 10 December 2018
Accepted: 10 December 2018
First Online: 13 December 2018
Conflict of interest
: OH has acquired research support (for the institution) from Roche, GE Healthcare, Biogen, AVID Radiopharmaceuticals, Fujirebio, and Euroimmun. In the past 2 years, he has received consultancy/speaker fees (paid to the institution) from Lilly, Roche, and Fujirebio. KW and HHC are employed at Genentech, South San Francisco, CA, USA. HZ has served at scientific advisory board meetings for Roche Diagnostics, Wave, Samumed, and CogRx, and is a co-founder of Brain Biomarker Solutions in Gothenburg AB, a GU Venture-based platform company at the University of Gothenburg. LP has served at scientific advisory board meetings for Fujirebio, IBL and Roche.